Case report: Metastatic cutaneous squamous cell carcinoma in an African American Female

Jennifer N. Harb, Alexandra L. Owens, Kathryn Mooneyham Potter, Michael Montuno, Reordan O. De Jesus, Sailesh Konda

Research output: Contribution to journalArticle

Abstract

Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer diagnosed in African Americans.1 Twenty to forty percent of cSCCs reported in African Americans are related to chronic scarring processes or areas of in ammation.2 Risk factors for developing cSCCs in patients of color include chronic scars resulting from burns, skin ulcers, and radiation sites; and chronic inflammatory diseases such as discoid lupus and hidradenitis suppuritiva.1 Although skin cancer only accounts for 1% to 2% of cancers diagnosed within African Americans, it is associated with increased morbidity and mortality in this population.1,3 Significant delays in diagnosis and treatment are largely thought to be responsible for this prognostic incongruity. The rate of metastasis in patients of color is 31%, compared with only 4% in Caucasians.4,5 Early recognition by physicians and increased awareness resulting in preventative measures by patients may decrease this noted disparity.

Original languageEnglish (US)
Pages (from-to)81-84
Number of pages4
JournalJournal of Drugs in Dermatology
Volume16
Issue number1
StatePublished - Jan 2017
Externally publishedYes

Fingerprint

African Americans
Squamous Cell Carcinoma
Skin Neoplasms
Skin
Cicatrix
Hidradenitis
Color
Skin Ulcer
Burns
Chronic Disease
Radiation
Neoplasm Metastasis
Morbidity
Physicians
Mortality
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Harb, J. N., Owens, A. L., Potter, K. M., Montuno, M., De Jesus, R. O., & Konda, S. (2017). Case report: Metastatic cutaneous squamous cell carcinoma in an African American Female. Journal of Drugs in Dermatology, 16(1), 81-84.

Case report : Metastatic cutaneous squamous cell carcinoma in an African American Female. / Harb, Jennifer N.; Owens, Alexandra L.; Potter, Kathryn Mooneyham; Montuno, Michael; De Jesus, Reordan O.; Konda, Sailesh.

In: Journal of Drugs in Dermatology, Vol. 16, No. 1, 01.2017, p. 81-84.

Research output: Contribution to journalArticle

Harb, JN, Owens, AL, Potter, KM, Montuno, M, De Jesus, RO & Konda, S 2017, 'Case report: Metastatic cutaneous squamous cell carcinoma in an African American Female', Journal of Drugs in Dermatology, vol. 16, no. 1, pp. 81-84.
Harb JN, Owens AL, Potter KM, Montuno M, De Jesus RO, Konda S. Case report: Metastatic cutaneous squamous cell carcinoma in an African American Female. Journal of Drugs in Dermatology. 2017 Jan;16(1):81-84.
Harb, Jennifer N. ; Owens, Alexandra L. ; Potter, Kathryn Mooneyham ; Montuno, Michael ; De Jesus, Reordan O. ; Konda, Sailesh. / Case report : Metastatic cutaneous squamous cell carcinoma in an African American Female. In: Journal of Drugs in Dermatology. 2017 ; Vol. 16, No. 1. pp. 81-84.
@article{ce50ca3cd6c443de99d82050b9b528ec,
title = "Case report: Metastatic cutaneous squamous cell carcinoma in an African American Female",
abstract = "Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer diagnosed in African Americans.1 Twenty to forty percent of cSCCs reported in African Americans are related to chronic scarring processes or areas of in ammation.2 Risk factors for developing cSCCs in patients of color include chronic scars resulting from burns, skin ulcers, and radiation sites; and chronic inflammatory diseases such as discoid lupus and hidradenitis suppuritiva.1 Although skin cancer only accounts for 1{\%} to 2{\%} of cancers diagnosed within African Americans, it is associated with increased morbidity and mortality in this population.1,3 Significant delays in diagnosis and treatment are largely thought to be responsible for this prognostic incongruity. The rate of metastasis in patients of color is 31{\%}, compared with only 4{\%} in Caucasians.4,5 Early recognition by physicians and increased awareness resulting in preventative measures by patients may decrease this noted disparity.",
author = "Harb, {Jennifer N.} and Owens, {Alexandra L.} and Potter, {Kathryn Mooneyham} and Michael Montuno and {De Jesus}, {Reordan O.} and Sailesh Konda",
year = "2017",
month = "1",
language = "English (US)",
volume = "16",
pages = "81--84",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "1",

}

TY - JOUR

T1 - Case report

T2 - Metastatic cutaneous squamous cell carcinoma in an African American Female

AU - Harb, Jennifer N.

AU - Owens, Alexandra L.

AU - Potter, Kathryn Mooneyham

AU - Montuno, Michael

AU - De Jesus, Reordan O.

AU - Konda, Sailesh

PY - 2017/1

Y1 - 2017/1

N2 - Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer diagnosed in African Americans.1 Twenty to forty percent of cSCCs reported in African Americans are related to chronic scarring processes or areas of in ammation.2 Risk factors for developing cSCCs in patients of color include chronic scars resulting from burns, skin ulcers, and radiation sites; and chronic inflammatory diseases such as discoid lupus and hidradenitis suppuritiva.1 Although skin cancer only accounts for 1% to 2% of cancers diagnosed within African Americans, it is associated with increased morbidity and mortality in this population.1,3 Significant delays in diagnosis and treatment are largely thought to be responsible for this prognostic incongruity. The rate of metastasis in patients of color is 31%, compared with only 4% in Caucasians.4,5 Early recognition by physicians and increased awareness resulting in preventative measures by patients may decrease this noted disparity.

AB - Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer diagnosed in African Americans.1 Twenty to forty percent of cSCCs reported in African Americans are related to chronic scarring processes or areas of in ammation.2 Risk factors for developing cSCCs in patients of color include chronic scars resulting from burns, skin ulcers, and radiation sites; and chronic inflammatory diseases such as discoid lupus and hidradenitis suppuritiva.1 Although skin cancer only accounts for 1% to 2% of cancers diagnosed within African Americans, it is associated with increased morbidity and mortality in this population.1,3 Significant delays in diagnosis and treatment are largely thought to be responsible for this prognostic incongruity. The rate of metastasis in patients of color is 31%, compared with only 4% in Caucasians.4,5 Early recognition by physicians and increased awareness resulting in preventative measures by patients may decrease this noted disparity.

UR - http://www.scopus.com/inward/record.url?scp=85028917433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028917433&partnerID=8YFLogxK

M3 - Article

C2 - 28914954

AN - SCOPUS:85028917433

VL - 16

SP - 81

EP - 84

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 1

ER -